We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Characterization of Patient-Reported Sleep and Mood Symptoms in Chronic Mild Traumatic Brain Injury: A Comprehensive Review

MedXY Editorial Team•Aug 17, 2026•Clinical Updates
mild traumatic brain injurycognitive impairmentmood disorderssleep disturbances

Highlights

  • High prevalence of diverse sleep disturbances including insomnia, excessive daytime sleepiness, and obstructive sleep apnea are reported in chronic mTBI patients, often coexisting with mood disorders.
  • Self-reported sleep impairments significantly correlate with neurobehavioral symptom severity, depression, and anxiety, underscoring complex symptom interdependencies.
  • Sleep quality improvement through targeted interventions may reduce depressive and post-traumatic symptoms and enhance neurocognitive outcomes.
  • Comprehensive screening for sleep disorders should be embedded within chronic mTBI care to optimize recovery and functional outcomes.

Background

Traumatic brain injury (TBI) affects approximately two million individuals annually in the United States, with mild traumatic brain injury (mTBI), often synonymous with concussion, constituting the majority of cases. While mTBI is characterized by transient neurological impairment, many patients develop chronic symptoms, including cognitive deficits, mood disturbances, and sleep disorders, contributing substantially to long-term disability and diminished quality of life. Sleep disturbances reported in mTBI include insomnia, excessive daytime sleepiness (EDS), and obstructive sleep apnea (OSA), with prevalence varying between 30% and 70%. The complex interplay among sleep impairments, mood symptoms, and cognitive dysfunction demands a better understanding to guide comprehensive management strategies.

Key Content

Patient-Reported Sleep and Mood Symptoms in Chronic mTBI

Johnson et al. (2026) conducted a cross-sectional retrospective analysis of 46 adults with chronic mTBI (>6 months post-injury) at a Level 1 trauma center, employing validated patient-reported measures: Neurobehavioral Symptom Inventory (NSI), Epworth Sleepiness Scale (ESS), STOP-Bang questionnaire, Insomnia Severity Index (ISI), Functional Outcome of Sleep Questionnaire-10 (FOSQ-10), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7). The cohort was predominantly male (74%) with a mean age of 53 years. Significant associations were identified between NSI scores and measures of daytime sleepiness, insomnia severity, sleep-related functional impairment, depression, and anxiety (p < 0.01 for all), after controlling for age, BMI, and time from injury. These findings corroborate chronic sleep and mood impairments tightly linked to neurobehavioral symptom burden in mTBI. Importantly, the study excluded substance-dependent individuals, increasing the specificity of results to injury-related factors.

Sleep Disturbance, Fatigue, and Cognitive Function Post-mTBI

Shany-Ur et al. (2021) investigated the relationship between sleep disturbance, fatigue, and cognitive performance in 60 premorbidly healthy adults approximately 8 weeks post-mTBI. Using the Pittsburgh Sleep Quality Index (PSQI), Multidimensional Fatigue Inventory, and neuropsychological assessments targeting processing speed, attention, memory, and executive function, they found sleep disturbance was strongly associated with poorer cognitive functioning (r2=0.586, p<0.001), especially executive function, independent of psychological distress and age. Intriguingly, higher fatigue correlated with better cognitive performance, potentially reflecting compensatory mechanisms. This study emphasizes the detrimental impact of sleep dysfunction on cognition early post-injury and implies that sleep interventions may enhance cognitive recovery.

Subjective Sleep Quality and Postconcussive Symptoms Severity

Siobhan et al. (2015) performed an online survey of 158 individuals with history of mTBI, assessing subjective sleep quality via PSQI alongside postconcussive symptoms (PCS) measured by NSI and psychological distress by Brief Symptom Inventory-18. A striking 92% reported poor sleep quality. Regression analyses demonstrated that subjective sleep quality significantly predicted PCS severity beyond demographic factors, time since injury, and psychological distress (p < 0.001), though psychological distress explained greater variance. This study highlights the ubiquity of poor sleep post-mTBI and its contributory role to persistent symptomatology.

Impact of Improved Sleep on Mood and Neurobiological Markers

Spoormaker et al. (2015) studied military personnel with insomnia, a population with relevant overlapping features given mTBI prevalence. Among 44 subjects undergoing cognitive behavioral therapy for insomnia and positive airway pressure treatment, those exhibiting improved sleep quality demonstrated significant reductions in depressive and posttraumatic arousal symptoms (p=0.005 and p=0.006, respectively) and increased insulin-like growth factor-1 (IGF-1) concentrations (p=0.009), a neurotrophic factor implicated in neuronal repair and neuroplasticity. This evidence suggests that sleep quality enhancement may attenuate mood symptom burden and promote neurobiological recovery mechanisms relevant in mTBI.

Integrative Perspectives on Mechanistic and Clinical Implications

Sleep disruption in mTBI likely arises from multifactorial etiologies, including neuroinflammatory cascades, autonomic dysregulation, and structural and functional network injuries affecting sleep regulation centers. Sleep disturbances exacerbate cognitive impairments, fatigue, and mood disorders, creating a vicious cycle that impairs recovery. Trophic factors such as IGF-1 and brain derived neurotrophic factor (BDNF) appear modulated by sleep states and may represent targets for enhancing neurorepair. Clinical interventions improving sleep, including cognitive behavioral therapy for insomnia and treatment of OSA, are associated with symptomatic and functional improvement.

Expert Commentary

The evidence consistently underscores the high prevalence of sleep disturbances among patients with chronic mTBI and their strong interrelationship with mood and cognitive symptoms. Johnson et al.’s study extends the literature by detailed phenotyping with multiple patient-reported instruments and statistically robust control of confounders, highlighting the critical need to comprehensively assess sleep symptoms in this population. The correlation between neurobehavioral symptom severity and sleep/mood parameters suggests that addressing sleep dysfunction may mitigate overall symptom burden.

However, limitations of current studies include reliance on subjective measures, limited sample sizes, and cross-sectional designs. Objective sleep assessments with polysomnography and longitudinal studies are required to unravel causal pathways and temporal patterns. Additionally, heterogeneity in injury mechanisms, comorbidities, and demographic factors complicate generalization. Future research should prioritize randomized controlled trials of tailored sleep interventions to determine their effect on mood, cognition, and functional recovery post-mTBI.

Conclusion

Chronic mTBI patients frequently experience persistent sleep disturbances, including insomnia and excessive daytime sleepiness, which strongly associate with mood symptoms and neurobehavioral impairments. Interventional studies suggest that improving sleep quality can alleviate depressive symptoms and may foster neurobiological recovery through modulation of trophic factors. These findings advocate for routine screening and integrated management of sleep disorders as a fundamental component of holistic mTBI care. Addressing sleep dysfunction holds promise to improve cognitive and emotional outcomes and reduce disability in this prevalent neurological condition.

References

  • Johnson K, Civantos AM, Patel N, et al. Characterization of Patient-Reported Sleep and Mood Symptoms in Chronic Mild Traumatic Brain Injury. Laryngoscope. 2026 Aug 16. PMID: 42604462.
  • Shany-Ur T, Woolard AA, Notenboom RGE, et al. An observational study of the association between sleep disturbance, fatigue and cognition in the post-acute period after mild traumatic brain injury. Neuropsychol Rehabil. 2021 Oct;31(9):1444-1465. PMID: 32558623.
  • Shores EA, Skarbinski J, Fortier CB, et al. Subjective sleep quality and postconcussion symptoms following mild traumatic brain injury. Brain Inj. 2015;29(11):1337-41. PMID: 26288022.
  • Spoormaker VI, Nyklícek I, van den Bout J. Improved Sleep Quality is Associated with Reductions in Depression and PTSD Arousal Symptoms and Increases in IGF-1 Concentrations. J Clin Sleep Med. 2015 Jun 15;11(6):615-23. PMID: 25766717.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Integrating Plasma p-tau217 and APOE Genotype to Predict Cognitive Decline Across Diverse PopulationsThis pooled analysis of seven multi-ethnic cohorts demonstrates the combined prognostic value of plasma phosphorylated tau 217 concentrations and APOE-ε4 genotype for predicting risk and timing of cognitive impairment, emphasizing biomarkerSep 13, 2026Navigating Surgical Decisions in Patients with Dementia: Clinician Challenges and InsightsThis article explores the complex challenges clinicians face in surgical decision-making for patients with dementia, highlighting issues with dementia identification, caregiver roles, and the influence of dementia on surgical outcomes.Aug 22, 2026Unraveling Dementia in Severe Schizophrenia: Distinct Cognitive Profiles and Genetic InsightsThis study reveals that dementia in severe, treatment-resistant schizophrenia exhibits a unique cognitive profile distinct from common neurodegenerative dementias and lacks typical genetic markers such as APOE4, highlighting a novel dementiJun 30, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Optimizing Mild Traumatic Brain Injury Care: Safely Reducing Transfers to Higher-Level Trauma Centers
Selective local management of mild traumatic brain injury with intracranial hemorrhage shows comparable safety and outcomes to transfer to level I trauma centers, reducing unnecessary patient transfers.
Jun 29, 2026
Left Atrial to Ventricular Volume Ratio: A Novel Imaging Biomarker Enhancing Detection of Atrial Cardiopathy and Stroke RiskThe left atrial to ventricular volume ratio (LA:LV ratio) emerges as a superior marker over left atrial volume index (LAVi) for atrial cardiopathy, showing stronger association with ischemic stroke risk, cognitive decline, and atrial fibrilJun 28, 2026
Harnessing Acoustic Analysis in Primary Care to Detect Cognitive Impairment: A Novel Screening ApproachMachine learning analysis of brief patient-physician conversations using acoustic speech features can effectively screen for cognitive impairment in primary care settings, enabling scalable early detection.Jun 28, 2026